Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IRIX

IRIDEX (IRIX)

IRIDEX Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRIX
DateTimeSourceHeadlineSymbolCompany
15/01/202505:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
14/01/202523:00GlobeNewswire Inc.Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024NASDAQ:IRIXIRIDEX Corporation
19/12/202408:05GlobeNewswire Inc.Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma ManagementNASDAQ:IRIXIRIDEX Corporation
20/11/202400:14GlobeNewswire Inc.Iridex Comments on Changing Glaucoma Reimbursement LandscapeNASDAQ:IRIXIRIDEX Corporation
14/11/202409:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
13/11/202408:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRIXIRIDEX Corporation
13/11/202408:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
13/11/202408:05GlobeNewswire Inc.Iridex Reports Third Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
09/11/202411:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
05/11/202408:05GlobeNewswire Inc.Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024NASDAQ:IRIXIRIDEX Corporation
04/10/202407:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
04/10/202406:05GlobeNewswire Inc.Iridex Appoints Patrick Mercer as Chief Executive OfficerNASDAQ:IRIXIRIDEX Corporation
26/09/202406:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IRIXIRIDEX Corporation
25/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRIXIRIDEX Corporation
06/09/202420:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
06/09/202406:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IRIXIRIDEX Corporation
09/08/202406:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRIXIRIDEX Corporation
09/08/202406:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
09/08/202406:05GlobeNewswire Inc.Iridex Reports Second Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
05/08/202423:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
05/08/202422:00GlobeNewswire Inc.Iridex Announces Convertible Note FinancingNASDAQ:IRIXIRIDEX Corporation
31/07/202406:05GlobeNewswire Inc.Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:IRIXIRIDEX Corporation
09/07/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
09/07/202406:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
01/06/202403:07Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:IRIXIRIDEX Corporation
31/05/202409:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
25/05/202408:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
25/05/202406:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
15/05/202407:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRIXIRIDEX Corporation
15/05/202406:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
 Showing the most relevant articles for your search:NASDAQ:IRIX